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Abstract Despite much success in drug design and develop-
ment, Pseudomonas aeruginosa is still considered as one of
the most problematic bacteria due to its ability to develop
mutational resistance against a variety of antibiotics. In search
for new strategies to enhance antibacterial activity of anti-
biotics, in this work, the combination effect of gold materials
including trivalent gold ions (Au3+) and gold nanoparticles
(Au NPs) with 14 different antibiotics was investigated
against the clinical isolates of P. aeruginosa, Staphylococcus
aureus and Escherichia coli. Disk diffusion assay was carried
out, and test strains were treated with the sub-inhibitory con-
tents of gold nanomaterial. Results showed that Au NPs did
not increase the antibacterial effect of antibiotics at tested
concentration (40 μg/disc). However, the susceptibility of
resistant P. aeruginosa increased in the presence of Au3+ and
methicillin, erythromycin, vancomycin, penicillin G, clinda-
mycin and nalidixic acid, up to 147 %. As an individual
experiment, the same group of antibiotics was tested for their
activity against clinical isolates of S. aureus, E. coli and a
different resistant strain of P. aeruginosa in the presence of
sub-inhibitory contents of Au3+, where Au3+ increased the
susceptibility of test strains to methicillin, erythromycin, van-
comycin, penicillin G, clindamycin and nalidixic acid. Our
finding suggested that using the combination of sub-inhibitory
concentrations of Au3+ and methicillin, erythromycin, nali-
dixic acid or vancomycinmay be a promising new strategy for
the treatment of highly resistant P. aeruginosa infections.
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Introduction
The emerging use of antibiotics has lead to microbial resis-
tance which is still considered as a major problem in che-
motherapy of many infectious diseases [1]. Many
mechanisms are involved in the process of antibiotic resis-
tances which mainly include enzymatic degradation and
modification of the antibiotic agent [2], modification of the
target site of the drug [3], and active reflux and reduced
uptake of the drug [4]. Pseudomonas aeruginosa is an
opportunistic human pathogen Gram negative bacterium
which is responsible for infections such as blood stream
nosocomial infections, especially in immunocompromised
patients and the elderly population of industrial societies [5].
The organism has reputation for having minimal nutritional
requirements, the ability to tolerate a wide variety of phys-
ical conditions and the ability to resist against new anti-
biotics such that it has been addressed as “the worst
nightmare” of microbiologists and clinical pharmacists for
its highly resistant nature [6]. The antibiotic resistance of
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this microorganism is due to a number of mechanisms
which mainly include co-operation of multidrug efflux
pumps such as MexAB-OprM, a pump system that removes
β-lactams, chloramphenicol, fluoroquinolones, macrolides,
novobiocin, sulfonamides, tetracycline and trimethoprim, as
well as various dyes and detergents [7]; low impermeability
of the membrane to drugs and the fact that it readily devel-
ops mutational resistance to most antibacterial agents [8].
The problem of multidrug resistance of P. aeruginosa has
urged many scientists and pharmaceutical companies to
search for new potential therapies for this Gram negative
bacterium [9–11]. Therefore, studies on new strategies to
combat P. aeruginosa would be of great value.
An alternative strategy to overcome the problem of resis-
tance is the use of commonly used antibiotics in combina-
tion with different natural or chemical agents [12, 13]. To
date, many organic and inorganic compounds have been
reported to enhance the antibacterial activity of different
antibiotics against many bacteria and fungi resistant test
strains [14]. Metallic ions and metallic nanoparticles includ-
ing zinc and silver have particularly shown promise when
used in combination with a number of antibiotics such as
ciprofloxacin [15], penicillin G, amoxicillin, erythromycin,
clindamycin, vancomycin [16], ampicillin, kanamycin,
erythromycin and chloramphenicol [17] in different Gram
positive or Gram negative test strains. In a recent approach,
Rai et al. reported the antibiotic mediated synthesis of Au
NPs with potent antimicrobial activity for application in
antimicrobial coatings [18].
During our previous attempts to explore new agents that
modulate antibiotic resistant, we screened different chemical
substances and natural products and reported a number of
organic and inorganic compounds which reduced the resis-
tance of various Gram positive and negative bacteria including
Staphylococcus aureus, Clostridium difficile and Aspergillus
sp. [14, 19]. In particular, our team reported that some mono-
terpenes (one of the major components of essential oils)
enhanced antibacterial activity of nitrofurantoin against resis-
tant strains of Enterobacteria [19]. We also showed that the
antibacterial activity of fluconazol against different species of
Aspergillus increased in the presence of different concentra-
tions of Sarcococca saligna ethanol extract [14]. In our very
recent work, we demonstrated the enhanced activity of cipro-
floxacin in the presence of ZnO nanoparticles [15]. We also
reported that silver nanoparticles enhance antibacterial activity
of different antibiotics against S. aureus and Escherichia coli
[16]. However, our search for finding new compounds that
enhance the activity of antibiotics against P. aeruginosa was
not successful during past years.
To date, gold-based drugs have shown great promise in
treatment of various diseases such as auranofin for the
treatment of arthritis and triphenylphosphinegold (I) com-
plexes for the treatment of cancer tumors, psoriasis and HIV
infections [20]. Moreover, gold complexes have shown con-
siderable cytotoxic and antimicrobial activity [21–23]. In
this study, we report the combination effect of Au3+ on
antibacterial activity of different antibiotics against clinical-
ly resistant strains of P. aeruginosa, S. aureus and E. coli.
Material and methods
Gold materials
Chloroauric acid was purchased from Merck, Darmstadt,
Germany. Au NPs used during this investigation were pre-
pared by previously described tannin-free ethanol extract of
black tea (Camellia sinensis) method [24]. Briefly, an aque-
ous chloroauric acid solution (10−3 M) was added separately
to the reaction vessel containing the tannin-free ethanol
extract of black tea (10 %v/v), and the resulting mixture
was allowed to stand for 15 min at room temperature. The
reduction of the Au3+ ions by tannin-free ethanol extract of
black tea in the solutions was monitored by sampling the
aqueous component (2 ml) and measuring the UV–visible
spectrum of the solutions. This sample was diluted three
times with distilled water, and the UV–visible spectrum of
this sample was measured on a Labomed Model UVD-2950
UV–Vis Double Beam PC Scanning spectrophotometer,
operated at a resolution of 2 nm. Furthermore, Au NPs were
characterized by transmission electron microscopy (model
EM 208 Philips). The gold colloid solution was centrufuged
(12000×g) for 60 min. Subsequently the setteled Au NPs
were washed three times with deionised water. A stock
colloid solution (100 mg/ml) was prepared and reserved in
4°C for further experiments.
Antimicrobial assay
The antibacterial activity of Au3+ and Au NPs was evaluated
at different contents (31.25, 62.5, 125, 250, 500, 1000, 2000
and 4000 μg/disc) on Müeller–Hinton agar (MHA) (Difco,
Germany) using conventional disk diffusion method against
P. aeruginosa, S. aureus and E. coli. Minimum inhibitory
content was defined as the lowest content of Au3+ or Au
NPs creating clear zone of inhibition after 24 h at 35°C. This
disk diffusion susceptibility test was also carried out on
MHA plates in order to examine the antibacterial activity
of candidate antibiotics against resistant test strains. Stan-
dard antibiotics disks, listed in Table 1, were purchased from
Mast Co., UK. In order to explore a possible combination
effect of gold materials and antibiotics, each standard paper
disk was impregnated with the sub-inhibitory content of
40 μg/disk of Au3+ and Au NPs. A resistant strain of P.
aeruginosa was obtained from Imam University Hospital
(Tehran, Iran) and identified by conventional microbiological
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and biochemical methods. A single colony of test strains was
grown overnight onMueller–Hinton broth (MHB)medium on
a rotator shaker (200 rpm) at 35°C. The inocula were prepared
by diluting the cultures with 0.9 % NaCl to a 0.5 McFarland
standard and were applied to the plates along with the standard
and test disks containing 40 μg/disk of Au3+ and Au NPs.
After incubation at 35°C for 24 h, the zones of inhibition were
measured. The mean surface area of each inhibition zone
(square millimeter) was calculated from the mean diameter
of each tested antibiotic. The percent of increase in the inhi-
bition zone areas for different antibiotics against P. aeruginosa
was calculated as (b2−a2)/a2×100 where a is the inhibition
zone in the presence of antibiotic only, and before addition of
Au3+ and AuNPs, while b represents the inhibition zone in the
presence of antibiotic plus Au3+ or Au NPs. The same proce-
dure was used for combination of Au3+ and Au NPs with
antibiotics against additional test strains. All experiments were
performed in triplicate.
Additionally, a different clinical isolate of P. aeruginosa
and two test strains of S. aureus and E. coli were obtained
from Ghods Polyclinic Laboratory (Tehran, Iran), and the
same procedure was repeated. To compare the antibacterial
activity results of test and control samples and in order to avoid
possible errors, a parallel test was run for pure antibiotics with
conditions similar to those for antibiotic–gold material
combination. The enhancing effect of Au3+ with different anti-
biotics was further determined against mentioned test strains
using the method described above (Table 1).
Results and discussion
In this study, the Au NPs were prepared using a tannin-free
ethanol extract of black tea. The inset to Fig. 1 shows the
tubes containing this tannin-free extract before (tubes A)
and after the reaction with Au3+ for 15 min (tubes B). The
gold-containing solutions (tubes A and B) that were a trans-
parent yellow at first turned into purple on completion of the
reaction by the tannin-free ethanol extract of black tea (tube
B). These reaction mixtures were further characterized by
UV–visible spectroscopy. As illustrated in Fig. 1, a strong
surface plasmon resonance maximum was observed at ca.
527 nm. This peak is assigned to a surface plasmon phe-
nomenon that is well documented for various metal nano-
particles with sizes ranging from 2 to 100 nm [25–27].
Figure 2 shows representative TEM images recorded from
the drop-coated film of the as-prepared Au NPs, synthesized
by treating the chloroauric acid solution with a tannin-free
ethanol extract of black tea (left picture) after 15 min. The
particle size histogram of these spherical gold particles,
produced with this tannin-free ethanol extract (right illustra-
tion) in Fig. 2), shows that the particles range in size from
1.25 to 17.5 nm. It should be mentioned that almost 60 % of
prepared Au NPs were in the range 2–6 nm.
The antibacterial effect of Au3+ and Au NPs against P.
aeruginosa, S. aureus and E. coli has been determened by
Table 1 The antibacterial activity of Au3+ ions and gold nanoparticles
against Pseudomonas aeruginosa, Staphylococcus aureus and Escher-
ichia coli
Compounds (μg/disk) Zone of inhibition diameter (mm)
E. coli P. aeruginosa (I) S. aureus
Au3+
4000 32 30 34
2000 28 24 30
1000 21 20 22
500 14 17 16
250 10 14 13
125 9 (MIC) 12 11
62.5 – 9 (MIC) 9 (MIC)
31.25 – – –
AU NPs
4000 14 14 13
2000 10 11 10 (MIC)
1000 9 (MIC) 9 (MIC) –
500 – – –
250 – – –
125 – – –
62.5 – – –
31.25 – – –
Minimum inhibitory content (MIC) was defined as the lowest content






















Fig. 1 UV–visible spectrum of gold colloid. Spectrum recorded after
adding the tannin-free ethanol extract of black tea (10 ml) to 90 ml of a
chloroauric acid solution (1 mM). The curve is recorded after a period of
15 min. The inset shows the solution of chloroauric acid (1 mM) before
(a) and after exposure to the tannin-free ethanol extract of black tea (b)
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disk diffusion method and reported in Table 1. Higher con-
centrations of both Au3+ and Au NPs (1000–4000 μg/disc)
showed antibacterial activity aganist above test strains. As
antibacterial agent, the Au3+ ions were considarably more
potent than inert Au NPs against all test strians. Lowest
MICs were obtained for Au3+ against P. aeruginosa, S.
aureus and E. coli (Table 1). In the next step, the antibacte-
rial activity of sub-inhibitory contents of Au3+ and Au NPs
was investigated in combination with a number of common-
ly used antibiotics against resistant strains of P. aeruginosa,
S. aureus and E. coli. The diameters of inhibition zones
(millimeter) in antibiotic disks both in the presence and ab-
sence of sub-inhibitory contents of Au3+ and Au NPs were
calculated. It should be noted that no antibacterial activity was
observed for both Au3+ and Au NPs at concentartions lower
than 62.5 μg/disk. In this investigation the sub-inhibitory
content of 40 μg/disk was chosen which is much lower than
the MIC value required to produce antibacterial effect. There-
fore, any increase in the antibacterial effect of antibiotics could
be attributed not to the cytotoxic effect of Au3+, but to the
combination effect of Au3+ with antibiotics.
Table 2 shows the inhibition zones (square millimeter) of
candidate antibiotics against two different strains of P. aer-
uginosa both in presence and absence of sub-inhibitory
content of 40 μg/disk Au3+. As shown in the Table 2,
different antibiotics showed different activities in the pres-
ence of Au3+. In both resistant P. aeruginosa isolates, the
antibacterial activity of penicillin G, methicillin, erythromy-
cin, vancomycin, clindamycin and nalidixic acid increased,
while no enhancing effect was observed for the remaining
antibiotics. In detail, the surface area of inhibition zones
(percent) in resistant P. aeruginosa strain 1 plates containing
either of methicillin, erythromycin, vancomycin, penicillin
G, clindamycin and nalidixic acid increased by 147, 147,
147, 104, 125 and 147 %, respectively.
Furthermore, the effect of Au3+ was evaluated using the
same set of antibiotics against a different clinical isolate of
P. aeruginosa and the clinical isolates of S. aureus and E.


























Fig. 2 Transmission electron
micrograph recorded from a
small region of a drop-coated
film of chloroauric acid solution
treated with the tannin-free eth-
anol extract of black tea (left-
side picture) for 15 min (scale
bars correspond to 50 nm). The
related particle size distribution
histogram (right-side picture)
obtained after measuring the
size of 350 individual particles
Table 2 Increase in inhibition zone area (%) of candidate antibiotics
against two resistant test strains of Pseudomonas aeruginosa, the
clinical isolates of Staphylococcus aureus and Escherichia coli in the
presence of Au+3 at sub-inhibitory content of 40 μg/disk
Antibiotics
(μg/disk)









Penicillin G 10 104 65 19 0
Amoxicillin 10 0 0 0 0
Methicillin 5 147 146 0 0
Cephalexin 30 0 0 0 30
Cefixime 5 0 0 0 0
Erythromycin
5
147 104 0 0
Gentamicin 10 0 0 7 0
Amikacin 30 0 0 7 9
Tetracycline 30 0 0 10 7
Ciprofloxacin
5
0 0 7 0
Clindamycin 2 125 65 13 65
Nitrofurantoin
300
0 0 8 21
Nalidixic acid
30
147 146 39 0
Vancomycin
30
147 104 0 147
Mean surface area of the inhibition zone (mm2 ) was calculated from
the mean diameter of each tested antibiotic. The percent of increase in
the inhibition zone areas in presence of sub-inhibitory contents of
Au+3 for different antibiotics against Pseudomonas aeruginosa was
calculated as (b2 −a2 )/a2 ×100 where a is the inhibition zone in the
presence of antibiotic only, and before inoculation of Au3+ , and b
represents the inhibition zone in the presence of antibiotic plus Au3+ .
No significant inhibition was observed when the combination of anti-
biotic–Au NPs was used under similar condition
56 Gold Bull (2012) 45:53–59
new isolate of P. aeruginosa to methicillin, erythromycin,
vancomycin, penicillin G, clindamycin and nalidixic acid
increased by 146, 104, 104, 65, 65 and 146 %, respectively.
However, the inhibition zone was not the same in different
clinical isolates of P. aeruginosa (104 % and 65 %). In S.
aureus group, Au3+ slightly enhanced the antibacterial ac-
tivity of penicillin G, gentamicin, amikacin, tetracycline,
ciprofloxacin, clindamycin, nitrofurantoin and nalidixic ac-
id. The most enhancing effects in this group were observed
for nalidixic acid (39 % increase) and clindamycin (13 %
increase). In E. coli group, Au3+ had enhancing effect on
antibacterial activity of cephalexin, amikacin, tetracycline,
clindamycin, nitrofurantoin and vancomycin, and the most
enhancing effect was observed for cephalexin (30 % in-
crease), clindamycin (65 % increase), nitrofurantoin (21 %
increase) and vancomycin (147 % increase).
The test was also repeated with the same set of antibiotics,
using the same sub-inhibitory content of 40 μg/disk Au NPs
against resistant P. aeruginosawhich showed that Au NPs did
not have a significant effect on antibacterial activity of anti-
biotics at a content level of 40 μg (results not shown).
In 2007, Grace and Pandium reported that Au NPs did
not have antibacterial effects against a number of micro-
organisms including P. aeruginosa, S. aureus and E. coli,
while coating of Au NPs with antibiotics increased their
antibacterial activity [28]. Furthermore, recent studies by
Burygin et al. revealed that Au NPs have no enhancing effect
on the antibacterial activity of gentamycin [26]. In this study,
no significant difference was observed between antibacterial
activity of antibiotics alone and their mixture with Au NPs.
However, as suggested by Burygin et al., it seems that Au NPs
enhance antibacterial activity of antibiotics only when antibi-
otic is chemically attached on the surface of Au NPs and
formed stable conjugates with particles rather than when used
in combination with antibiotics as a mixture [29]. Therefore,
comparing Au NPs and Au3+, it is plausible that Au3+ form
more potent mixtures with antibiotics concerning the fact that
they are more actively involved in reactions due to their ionic
nature. This probably best explains our finding that when used
together with antibiotics, Au NPs had no significant effect on
antibacterial activity of antibiotics, while Au3+ (which form
more potent complexes) enhanced the inhibition zone of bac-
terial growth.
Comparing four groups, it seems that the enhancing
effect of Au3+ was more considerable in Gram negative P.
aeruginosa and E. coli rather than Gram positive S. aureus.
It is notable that studies of Marques et al. on MIC (minimum
inhibitory concentration) value of Au3+ metal compounds in
complex with sulphamethoxazole in P. aeruginosa, E. coli
and S. aureus suggested no difference between the response
of Gram positive and Gram negative bacteria treated with
Au compounds in combination with sulphamethoxazole
[30], while other studies suggest that the enhancing effect
of Au3+ is better in Gram negative bacteria [31]. However,
more investigations should be carried out at the molecular
level to clarify whether Au3+ is more effective on Gram
negative rather than Gram positive bacteria.
Fourteen candidate antibiotics were carefully chosen
since they represent major classes of antibiotics (penicillins,
cephallosporins, macrolides, aminoglicosides, tetracyclines,
fluoroquinolones, lincomycin derivatives, nitrofurans and
glycopeptides). However, different antibiotics showed dif-
ferent activities in the presence of Au3+. In P. aeruginosa, a
considerable enhancing effect was observed for methicillin,
erythromycin, vancomycin, penicillin G, clindamycin and
nalidixic acid, while in S. aureus Au3+ slightly enhanced the
antibacterial activity of penicillin G, gentamicin, amikacin,
tetracycline, ciprofloxacin, clindamycin, nitrofurantoin and
nalidixic acid. In E. coli group, Au3+ had an enhancing
effect on antibacterial activity of cephalexin, amikacin, tet-
racycline, clindamycin, nitrofurantoin and vancomycin.
It is already known that Au 3+ may form a coordination
complex with available donor groups such as nitrogen,
sulfur and phosphor. Therefore, in the presence of antibiot-
ics such as penicillin, nalidixic acid and clindamycin, Au 3+
may form coordination complexes with ring nitrogen on
these compounds. This interaction may have induced
changes in morphology of these compounds, thereby in-
creasing their efficiency. The same mechanism has been
proposed for the interaction of gold (III) with zeatin [32].
In beta-lactam and cephalosporins such as penicillin and
methicillin, this coordination may have happened between
Au3+ and free electrons on sulphur and nitrogen donor
groups. However, this was not the case for all beta-lactam
and cephalosporins tested (amoxicillin and cefixime).
It is also deducible that the enhancing effect of Au3+ was
more significant in Gram negative P. aeruginosa and E. coli
rather than the Gram positive S. aureus. This is potentially
interesting since studies by Chudasama et al. on core–shell
silver nanostructures [33] and Nomiya et al. on gold (I)
complexes [21] also revealed that gold complexes are con-
siderably more effective on Gram negative rather than Gram
positive bacteria. However, further investigations are sug-
gested to be carried out on other Gram positive and Gram
negative strains to see whether the structure of cell wall in
bacteria affects the enhancing effect of gold materials.
So far, a number of elements including copper, lead and
zinc have been studied for their interaction with P. aerugi-
nosa [28, 34]. As mentioned earlier, the antibiotic resistance
of P. aeruginosa is primarily due to the co-operation of
multidrug efflux pumps and impermeability of bacterial
membrane [6]. Therefore, it is possible that Au3+ may sen-
sitize P. aeruginosa cells by either interfering in the function
of these efflux pumps or increasing the permeability of the
bacterial membrane. Moreover, P. aeruginosa is well known
for its resistance to heavy metals through reduction of metal
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ions. For instance, it actively resists against Au3+ through
reducing it to its metallic form [35, 36]. However, when
treated with the combination of antibiotic–Au3+, P. aerugi-
nosa was more sensitive to the antibiotics. This could be due
to the possible new interactions that may form between
antibiotics and Au3+ which literally hinder P. aeruginosa
from reducing it to metallic Au and the fact that the organ-
ism may not be able to reduce heavy metal ions in the
presence of antibiotics. However, more experiments are
required to be done in order to determine the underlying
mechanism of Au3+ in the presence of antibiotics. The
mechanism underlying the enhancing effect of Au3+ is prob-
ably multi-factorial, and a molecular approach is necessary
to identify the determinants of this effect.
Conclusion
The result of this work demonstrates that using Au3+, it is
possible to enhance the efficacy of a number of commonly
used antibiotics against P. aeruginosa up to 146 %. This
finding is of particular value since resistant strains of P.
aeruginosa are considered as a major problem in chemo-
therapy of many infectious diseases. This enhancing effect
also occurred in other resistant microorganisms including S.
aureus and E. coli. This suggests that the combination
therapy of gold materials such as Au3+ could be considered
as a new approach and the common antibiotics may have an
even broader range of medical applications in the future.
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